BIOMAT Database Logo BIOMAT Database Logo

[Isolation and properties of genetic engineered human leukocyte interferons alphaI1 and alphaN]. 1988

M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov

Using controlled pore glass chromatography and immunoaffinity chromatography on monoclonal antibodies NK-2 immobilized on Sepharose 4B, the electrophoretically homogeneous interferons alpha N and alpha I1 were isolated from the biomass of gene-engineered Pseudomonas sp. strains. In terms of specific activity on human fibroblast diploid cells, interferon alpha I1 does not differ from interferon alpha A, whereas the specific antiviral activity of interferon alpha N is as low as 2.10(7) JU/mg. The procedures for immunometric assay of interferons alpha N and alpha I1 have been elaborated. Various monoclonal antibodies to interferon alpha A and to natural leucocyte interferon were analyzed; among those the antibodies specifically interacting with interferons alpha N and alpha I1 (but not with interferon alpha A) were identified.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
[Comparative study of the biological properties of swine and human leukocyte interferons].
January 1980, Voprosy virusologii,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
[Isolation and properties of monomeric and oligomeric forms of gene-engineered human leukocyte interferon alphaA from Pseudomonas sp].
October 1988, Biokhimiia (Moscow, Russia),
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Antigenic properties of crossprotecting factors in human leukocyte and mouse L cell interferons.
January 1980, Annals of the New York Academy of Sciences,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
ISOLATION AND PROPERTIES OF HUMAN LEUKOCYTE LYSOSOMES IN VITRO.
May 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Pharmacology of interferons I. Pharmacologic distinctions between human leukocyte and fibroblast interferons.
January 1979, International journal of immunopharmacology,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Enzymatic modifications of human fibroblast and leukocyte interferons.
August 1980, Journal of virology,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Antiproliferative and antiviral activities of human leukocyte interferons.
August 1981, Archives of biochemistry and biophysics,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Human leukocyte and fibroblast interferons are structurally related.
June 1980, Nature,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
[Preparation and purification of human leukocyte interferons (author's transl)].
June 1980, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
M R Eremashvili, and S I Borukhov, and V I Bakhutashvili, and V A Naroditskaia, and A Iu Chistoserdov
Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons.
June 1976, The Journal of infectious diseases,
Copied contents to your clipboard!